GE Revises Instrumentarium Buy-Out Date In Face Of Anti-Trust Scrutiny
This article was originally published in The Gray Sheet
Executive Summary
GE Medical Systems' decision to extend the timing of its tender offer for Instrumentarium suggests the company may be forced to divest some critical care or imaging assets in order for the merger to earn European and U.S. anti-trust approval